VI
Vigil Neuro
VIGL·NASDAQWatertown MAFounded 202040 employees
Micro CapbiotechPublicNeurology
Platform: TREM2
Market Cap
$0.15B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (VIGL)
Loading VIGL stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| VIG-6767 | VIG-6767 | Phase 2/3 | 2 | CD47 | SchizophreniaRett | ||
| VIG-1206 | VIG-1206 | Phase 3 | 1 | CFTR | ALSGIST |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)